Position in LLY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$3,032,159
+$808,156 QoQ
Shares Held
2,528
+4.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
#2,118
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Monument Capital Management holds $17,122,223 across 11 Drug Manufacturers - General names. LLY ranks #2 (17.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
18,097 | $4,596,095 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
2,528 | $3,032,159 | |
| 3 | MRK |
Merck & Co., Inc.
|
22,665 | $2,912,452 | |
| 4 | ABBV |
AbbVie Inc.
|
6,503 | $1,636,414 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,267 | $1,549,812 | |
| 6 | AMGN |
Amgen Inc
|
2,614 | $946,581 | |
| 7 | NVS |
Novartis AG
|
5,076 | $795,510 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,867 | $741,396 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,032,159 | 2,528 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $2,224,003 | 2,418 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $2,609,323 | 2,428 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $1,843,408 | 2,416 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $2,018,982 | 2,590 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $2,227,479 | 2,697 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $2,098,296 | 2,718 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $2,506,324 | 2,829 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $2,573,089 | 2,842 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $2,268,531 | 2,916 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $1,677,643 | 2,878 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,503,964 | 2,800 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $1,303,295 | 2,779 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $897,699 | 2,614 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $1,039,717 | 2,842 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $841,680 | 2,603 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,170,794 | 3,611 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $922,970 | 3,223 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $614,037 | 2,223 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $489,132 | 2,117 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $475,565 | 2,072 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $311,428 | 1,667 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $2,697,050 | 15,974 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $2,274,179 | 15,364 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $2,575,984 | 15,690 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $2,315,652 | 16,693 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||